134 related articles for article (PubMed ID: 15554359)
1. Residues 34-39 in the thyrotropin receptor are not the target of autoantibodies from sera of patients with Graves' disease.
Piotrowska U; Adler G; Kilianski J
Endocr Res; 2004 Aug; 30(3):431-41. PubMed ID: 15554359
[TBL] [Abstract][Full Text] [Related]
2. Cross-reactivity of a monoclonal antibody to the amino terminal region of thyrotropin receptor with the serum protein alpha(1)-antitrypsin.
Piotrowska U; Adler G; Gardas A; Gietka-Czernel M; Kaniewski M; Banga JP
Thyroid; 2002 Jul; 12(7):563-70. PubMed ID: 12193299
[TBL] [Abstract][Full Text] [Related]
3. Differences between thyrotropin receptor antibody bioactivity and inhibition of 125I-bovine thyrotropin binding.
Wallaschofski H; Kaczmarek M; Miehle K; Hentschel B; Paschke R
Thyroid; 2000 Oct; 10(10):897-907. PubMed ID: 11081256
[TBL] [Abstract][Full Text] [Related]
4. Graves' immunoglobulins activate phospholipase A2 by recognizing specific epitopes on thyrotropin receptor.
Di Cerbo A; Di Paola R; Menzaghi C; De Filippis V; Tahara K; Corda D; Kohn LD
J Clin Endocrinol Metab; 1999 Sep; 84(9):3283-92. PubMed ID: 10487700
[TBL] [Abstract][Full Text] [Related]
5. Engineering the human thyrotropin receptor ectodomain from a non-secreted form to a secreted, highly immunoreactive glycoprotein that neutralizes autoantibodies in Graves' patients' sera.
Chazenbalk GD; Jaume JC; McLachlan SM; Rapoport B
J Biol Chem; 1997 Jul; 272(30):18959-65. PubMed ID: 9228077
[TBL] [Abstract][Full Text] [Related]
6. The effect of thyrotropin-receptor blocking antibodies on stimulating autoantibodies from patients with Graves' disease.
Lenzner C; Morgenthaler NG
Thyroid; 2003 Dec; 13(12):1153-61. PubMed ID: 14751037
[TBL] [Abstract][Full Text] [Related]
7. Detection of functionally different types of pathological autoantibodies against thyrotropin receptor in Graves' patients sera by luminescent immunoprecipitation analysis.
Minich WB; Loos U
Exp Clin Endocrinol Diabetes; 2000; 108(2):110-9. PubMed ID: 10826518
[TBL] [Abstract][Full Text] [Related]
8. TSH receptor antibodies do not alter the function of gonadotropin receptors stably expressed in eukaryotic cells.
Tonacchera M; Ferrarini E; Dimida A; Agretti P; De Marco G; De Servi M; Chiovato L; Cetani F; Vitti P; Pinchera A
Eur J Endocrinol; 2004 Mar; 150(3):381-7. PubMed ID: 15012625
[TBL] [Abstract][Full Text] [Related]
9. Evidence that TSH Receptor A-Subunit Multimers, Not Monomers, Drive Antibody Affinity Maturation in Graves' Disease.
Rapoport B; Aliesky HA; Chen CR; McLachlan SM
J Clin Endocrinol Metab; 2015 Jun; 100(6):E871-5. PubMed ID: 25856215
[TBL] [Abstract][Full Text] [Related]
10. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay.
Morgenthaler NG; Hodak K; Seissler J; Steinbrenner H; Pampel I; Gupta M; McGregor AM; Scherbaum WA; Banga JP
Thyroid; 1999 May; 9(5):466-75. PubMed ID: 10365678
[TBL] [Abstract][Full Text] [Related]
11. Thyrotropin (TSH) receptor autoantibodies do not appear to bind to the TSH receptor produced in an in vitro transcription/translation system.
Prentice L; Sanders JF; Perez M; Kato R; Sawicka J; Oda Y; Jaskolski D; Furmaniak J; Smith BR
J Clin Endocrinol Metab; 1997 Apr; 82(4):1288-92. PubMed ID: 9100609
[TBL] [Abstract][Full Text] [Related]
12. A full biological response to autoantibodies in Graves' disease requires a disulfide-bonded loop in the thyrotropin receptor N terminus homologous to a laminin epidermal growth factor-like domain.
Chen CR; Tanaka K; Chazenbalk GD; McLachlan SM; Rapoport B
J Biol Chem; 2001 May; 276(18):14767-72. PubMed ID: 11278376
[TBL] [Abstract][Full Text] [Related]
13. Epitopes for thyroid stimulating and blocking autoantibodies on the extracellular domain of the human thyrotropin receptor.
Tahara K; Ishikawa N; Yamamoto K; Hirai A; Ito K; Tamura Y; Yoshida S; Saito Y; Kohn LD
Thyroid; 1997 Dec; 7(6):867-77. PubMed ID: 9459630
[TBL] [Abstract][Full Text] [Related]
14. The prevalence and clinical significance of blocking thyrotropin receptor antibodies in untreated hyperthyroid Graves' disease.
Kim WB; Chung HK; Park YJ; Park DJ; Tahara K; Kohn LD; Cho BY
Thyroid; 2000 Jul; 10(7):579-86. PubMed ID: 10958310
[TBL] [Abstract][Full Text] [Related]
15. [The cysteine bonding in TSH receptor and it function in autoantibodies recognition].
Adler G; Piotrowska U
Endokrynol Pol; 2005; 56(5):766-72. PubMed ID: 16817142
[TBL] [Abstract][Full Text] [Related]
16. Immunoprecipitation analysis of pathological autoantibodies in Graves' patients' sera using biotinylated human thyrotropin receptor labeled with 125I-neutravidiny.
Minich WB; Weymayer JD; Loos U
Exp Clin Endocrinol Diabetes; 1999; 107(8):555-60. PubMed ID: 10612487
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of a monoclonal antibody to the thyrotropin receptor that acts as a powerful thyroid-stimulating autoantibody antagonist.
Sanders J; Allen F; Jeffreys J; Bolton J; Richards T; Depraetere H; Nakatake N; Evans M; Kiddie A; Premawardhana LD; Chirgadze DY; Miguel RN; Blundell TL; Furmaniak J; Smith BR
Thyroid; 2005 Jul; 15(7):672-82. PubMed ID: 16053383
[TBL] [Abstract][Full Text] [Related]
18. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
[TBL] [Abstract][Full Text] [Related]
19. A prion-like shift between two conformational forms of a recombinant thyrotropin receptor A-subunit module: purification and stabilization using chemical chaperones of the form reactive with Graves' autoantibodies.
Chazenbalk GD; McLachlan SM; Pichurin P; Yan XM; Rapoport B
J Clin Endocrinol Metab; 2001 Mar; 86(3):1287-93. PubMed ID: 11238522
[TBL] [Abstract][Full Text] [Related]
20. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding.
Dallas JS; Cunningham SJ; Patibandla SA; Seetharamaiah GS; Morris JC; Tahara K; Kohn LD; Prabhakar BS
Endocrinology; 1996 Aug; 137(8):3329-39. PubMed ID: 8754759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
